Analyst Research
| Report Title | Price |
|---|---|
|
Provider: ValuEngine, Inc.
|
$127.00
|
|
Provider: Wright Reports
|
$472.00
|
|
Provider: GlobalData
|
$250.00
|
|
Provider: Finlabo SIM Spa
|
$58.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
EnWave Corp Signs Research Evaluation Agreement with Merck KGaA
EnWave Corp announced that it has signed a Research Evaluation Agreement with Merck, through a subsidiary. Under the terms of the agreement Merck will conduct a field test to determine the feasibility of the Radiant Energy Vacuum (REV) Technology using EnWave's new multi-vial pilot-scale equipment. In addition, EnWave has granted Merck an exclusive research license to use the Company's technology and licensed patents for the duration of the evaluation and an option to obtain an exclusive commercial worldwide license to EnWave's portfolio.
Latest Key Developments in Pharmaceuticals
- Share this
- Link this
- Digg this
Follow Reuters